Spinal cord ischemia/injury

T. Ishikawa, H. Suzuki, K. Ishikawa, S. Yasuda, T. Matsui, M. Yamamoto, T. Kakeda, S. Yamamoto, Y. Owada, T. L. Yaksh

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)


A spinal cord injury leads to disturbances of sensory and motor signals due to the damage to white matter and myelinated fiber tracts. Moreover, the damage to gray matter causes segmental loss of interneurons of dorsal horn and motoneurons and restricts the therapeutic options. Neuroprotective strategies have the potential to improve the neurological outcome of patients. To achieve this, concerns to anesthetics or analgesics as neuroprotective interventions have been accumulating to explore neuroprotection during perioperative period. This review includes consideration of: 1) basic concepts of the pathophysiological mechanisms following spinal cord injury and 2) anesthetics and analgesics displaying neuroprotective potential. In particular, we review the application of isoflurane as an inhalational neuroprotectant and discuss evidence for the neuroprotection provided by barbiturates. In addition, 3) recent advances in stem cell biology, neural injury and repair, and progress toward the development of neuroprotective and regenerative interventions are the basis for increased optimism.

Original languageEnglish
Pages (from-to)5738-5743
Number of pages6
JournalCurrent Pharmaceutical Design
Issue number36
Publication statusPublished - 2014 Jan 1
Externally publishedYes


  • Analgesic
  • Anesthetics
  • Barbiturates
  • Cellbased therapy/ transplantation
  • Hypothermia
  • Isoflurane
  • Neuroprotection
  • Preconditioning
  • Spinal cord ischemia/injury

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery


Dive into the research topics of 'Spinal cord ischemia/injury'. Together they form a unique fingerprint.

Cite this